Non-small cell lung cancer has been the subject of sustained clinical investigation across multiple research sites.

66 total trials for this combination

Showing top 10 of 66 trials

Trials

NCT ID	Title	Status	Phase
NCT01803282	Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors	COMPLETED	PHASE1
NCT03170960	Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors	ACTIVE_NOT_RECRUITING	PHASE1
NCT06465069	A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors	RECRUITING	PHASE1
NCT02526017	Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers	COMPLETED	PHASE1
NCT06774963	A Phase 1 Study of LNCB74 in Advanced Solid Tumors	RECRUITING	PHASE1
NCT04140526	Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC	ACTIVE_NOT_RECRUITING	PHASE1/PHASE2
NCT03452774	SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	RECRUITING	—
NCT02568267	Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)	ACTIVE_NOT_RECRUITING	PHASE2
NCT06561386	A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%	RECRUITING	—
NCT03149549	PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors	TERMINATED	PHASE1/PHASE2

Related Pages

All Non-small cell lung cancer trials All trials in Salt Lake City, United States